Editorial Office, Journal of Neuroscience and Neuropharmacology, Brussels, Belgium
Opinion
Metabolic Syndrome's Effect on the Development of Neurodegenerative Diseases
Author(s): Keith Herbert*
Metabolic Syndrome (MetS) and Neurodegenerative Diseases (NDD), such as Alzheimer's disease, Huntington's disease, Parkinson's disease, and depression, are both impacted by the Brain-Derived Neurotrophic Factor (BDNF). If one element is crucial to the pathogenesis of two diseases, then it is likely that these two diseases share the same underlying cause. This study intended to emphasize the significant roles of BDNF in the pathogenesis of MetS and NDD and to propose two distinct preventative or therapeutic approaches, BDNF gene therapy, and BDFN administration, for managing MetS and NDD. One might list cardiometabolic disorders including atherosclerosis, hypertension, Type 2 Diabetes Mellitus (T2DM), obesity, diabetes, and Metabolic Syndrome (MetS) as some of the most prevalent worldwide pathologies. Based on the justification that obesity is one of the main causes of T2DM.. View More»
DOI:
10.4172/2469-9780.2022.8.4.182
